Submit manuscript...
International Journal of
eISSN: 2381-1803

Complementary & Alternative Medicine

Commentary Volume 14 Issue 3

Repurposing of herbal medicine used for the treatment of respiratory infections to aid the control of COVID-19 pandemic

Gemmechu Hasen, Hawi Hussen, Sultan Suleman

1 Department of Pharmacy, Jimma University, Ethiopia
2Jimma University Laboratory of Drug Quality (JuLaDQ), Ethiopia
3 Department of Environmental Health, Jimma University, Ethiopia

Correspondence: Gemmechu Hasen, Department of Pharmacy, Jimma University, Oromia, Ethiopia

Received: September 20, 2020 | Published: May 7, 2021

Citation: Hasen G, Hussen H, Suleman S. Repurposing of herbal medicine used for the treatment of respiratory infections to aid the control of COVID-19 pandemic. Int J Complement Alt Med. 2021;14(3):97-98. DOI: 10.15406/ijcam.2021.14.00539

Download PDF

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic disease, and has reached a new dimension with a higher death ratio. Repurposing of known drug molecules against COVID-19 has become an elegant strategy to quickly develop effective therapies. On other hand, herbal medicines have been issued for the prevention and treatment of COVID-19. Thus, repurposing of the herbal medicine used against respiratory infections for management of COVID-19 is the novel approach to seek for remedies of COVID 19 pandemic as relief of the respiratory symptoms are the best options to mitigate the severity of the novel virus. Accordingly, the potential herbal medicines are recommended for the treatment of COVID 19, which are previously used for treatment of respiratory infections.

Keywords: herbal medicine, repurposing, COVID-19, respiratory infections

Abbreviations

COVID-19, coronavirus disease 2019; WHO, world health organization; HCQ, hydroxychloroquine; CQ, chloroquine

Commentary

Coronavirus disease 2019 (COVID-19) is a global pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) that was first identified in the city of Wuhan, Hubei Province, China, at the end of 2019.1 On January 30, 2020 the World Health Organization (WHO) declared the outbreak as a Public Health Emergency of International Concern, and has reached a new dimension with a higher death ratio.2 Since then international health care authorities have been working to provide quarantine and quick diagnosis for COVID-19 patients along with research to find an effective treatment that can control and prevent the present devastating novel COVID-19 pandemic.3 Accordingly various strategies have been proposed to control and prevent the spread of this epidemic. Among them repurposing of known drug molecules against COVID-19 has become an elegant strategy to quickly develop effective therapies as traditional drug development process is tedious, expensive and will consume many years.4 Among the repurposed drugs, the commonly used antimalarials chloroquine (CQ) and hydroxychloroquine (HCQ) have become the focus of global scientific, media, and political attention.5 As such some researchers have promoted chloroquine and hydroxychloroquine for the treatment and prevention of illness from a variety of microorganisms, including SARS-CoV.6 However, some countries opposed the use of these drugs because of adverse effects associated with drug repurposing and lack of statistically significant clinical data.7 On the other hand, use of scientifically-proven traditional medicine herbal medicines are welcomed by World Health Organization,8 and has been considered as treatment approach option for treatment of COVID-19 pandemic.9 To date, many guidelines related to herbal medicine have been issued for the prevention and treatment of COVID-19. However, recently anticipated herbal medicines need a further ethnobotanical and physiochemical studies, which will take more time to be used. Thus, repurposing of the herbal medicine used against respiratory infections for management of COVID-19 is the novel approach to seek for remedies of COVID 19 pandemic as relief of the respiratory symptoms are the best options to mitigate the severity of the novel virus. Accordingly, the following potential herbal medicines are recommended for the treatment of COVID 19, which are previously used for treatment of respiratory infections. For instances, spray application of five aromatic plants (Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus officinalis) will bring about significant and immediate improvement in symptoms of upper respiratory ailment such as sore throat, hoarseness or cough as reported by a recent Randomized Study Using Aromatic Herbs.10

Moreover, recently reported three herbs from the Apiaceae family—Ligusticum spp. (osha´, oshala), Lomatium dissectum (desert parsley, lomatium), and Osmorhiza occidentalis (western sweet Cicely) are all clinically potent respiratory-tract antivirals that are also immune stimulant and inflammation modulating.11 Thus these potential herbal medicines will contribute to control of the consequences of the COVID-19 pandemic. Generally, plant families of Asteraceae, Fabaceae, Lamiaceae, Solanaceae, Apiaceae family and Amaryllidaceae accounted highest number species of used for treatment of respiratory infections as reported in different literatures.12–14 Therefore, the uses of these potential herbal medicines are highly recommended for treatment of COVID-19 pandemic.

Acknowledgments

Not applicable.

Conflicts of interest

Author declares that there are no conflicts of interest.

Funding

None.

References

  1. Yang M, Hu Z, Yue R. Efficacy and safety of Chinese herbal medicine for Coronavirus disease 2019. Medicine (Baltimore). 2020;99(22):e20157.
  2. World Health Organization (WHO). COVID 19 Public Health Emergency of International Concern (PHEIC). Global research and innovation forum: towards a research roadmap. Geneva: World Health Organization; 2020.
  3. Khan Z, Karataş Y, Ceylan AF, et al. COVID-19 and therapeutic drugs repurposing in hand: The need for collaborative efforts. Pharm Hosp Clin. 2020;56(1):3–11.
  4. Parvathaneni V, Gupta V. Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges. Life Sci. 2020;259:118275.
  5. Abena PM, Decloedt EH, Bottieau E, et al. Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: Caution for inappropriate off-label use in healthcare settings. Am J Trop Med Hyg. 2020;102(6):1184–1188.
  6. Rolain JM, Colson P, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents. 2007;30(4):297–308.
  7. Pawar AY. Combating devastating COVID-19 by drug repurposing. Int J Antimicrob Agents. 2020;56.
  8. World Health Organization (WHO). WHO supports scientifically-proven traditional medicine. Geneva: World Health Organization; 2020.
  9. Ang L, Lee HW, Choi JY, et al. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res. 2020;9(2):100407.
  10. Ben-Arye E, Dudai N, Eini A, et al. Treatment of upper respiratory tract infections in primary care: A randomized study using aromatic herbs. Evidence-based Complement Altern Med. 2011;2011.
  11. Yarnell E. Herbs for Viral Respiratory Infections. Altern Complement Ther. 2018;24(1):35–43.
  12. Semenya SS, Maroyi A. Data on medicinal plants used to treat respiratory infections and related symptoms in South Africa. Data Br. 2018;21:419–23.
  13. Alamgeer, Younis W, Asif H, et al. Traditional medicinal plants used for respiratory disorders in Pakistan: A review of the ethno-medicinal and pharmacological evidence Milen Georgiev, Ruibing Wang. Chinese Med (United Kingdom). 2018;13(1).
  14. Lawal IO, Olufade II, Rafiu BO, et al. Ethnobotanical survey of plants used for treating cough associated with respiratory conditions in Ede south local government area of Osun State, Nigeria. Plants. 2020;9(5).
Creative Commons Attribution License

©2021 Hasen, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.